NCT01124617: A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia |
|
|
| Completed | 2 | 91 | Japan | Tapentadol, JNS024ER, Placebo | Janssen Pharmaceutical K.K. | Pain, Diabetic Neuropathies, Neuralgia, Postherpetic Neuralgia | 04/11 | 04/11 | | |